The effect of the duration of clopidogrel use on hsCRP levels after stenting the target vessel in patients with acute coronary syndrome

被引:0
|
作者
Cekici, Y. [1 ]
Korkmaz, H. [1 ]
Akbulut, M. [2 ]
Celik, A. [1 ]
机构
[1] Elazig Educ & Res Hosp, Elazig, Turkey
[2] Firat Univ, TR-23169 Elazig, Turkey
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:259 / 259
页数:1
相关论文
共 50 条
  • [31] Aspirin and Clopidogrel response in patients with acute coronary syndrome
    Braga, F.
    Lavall, G.
    Sterque, A.
    Albuquerque, F.
    Gouvea, G.
    Neno, A. C.
    Kezen, J.
    Max, R.
    Sophia, E.
    Hellmuth, B.
    CIRCULATION, 2008, 118 (12) : E291 - E291
  • [32] Comparable outcomes on single use of clopidogrel vs. dual antiplatelet therapy after coronary stenting in patients with acute myocardial infarction
    Oh, Jun-Hyok
    Cha, Kwang Soo
    Lee, Dae-Sung
    Lee, Han Cheol
    Lee, Hye Won
    Hong, Taek Jong
    Shin, Donghun
    Choi, Jung Hyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B147 - B147
  • [33] Examination of clopidogrel patterns of use in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe
    Smith, H.
    Mccollam, L.
    Nasuti, P.
    Bae, J. P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 785 - 785
  • [34] Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome
    Gaspar, Antonio
    Ribeiro, Silvia
    Nabais, Sergio
    Rocha, Sergia
    Azevedo, Pedro
    Pereira, Miguel Alvares
    Brandao, Aida
    Salgado, Alberto
    Correia, Adelino
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2010, 29 (10) : 1511 - 1520
  • [35] PATTERNS OF ACUTE CLOPIDOGREL USE AND INPATIENT COSTS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING
    Johnston, S. S.
    Bell, K.
    Bergeson, Gdovin J.
    McMorrow, D.
    Graham, J.
    VALUE IN HEALTH, 2011, 14 (03) : A87 - A87
  • [36] The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry
    Ferlini, Marco
    Musumeci, Giuseppe
    Grieco, Niccolo
    Rossini, Roberta
    De Servi, Stefano
    Mafrici, Antonio
    Sponzilli, Carlo
    Demarchi, Andrea
    Assanelli, Emilio M.
    Camisasca, Paola
    Chizzola, Giuliano
    Corrada, Elena
    Farina, Andrea
    Pedrinazzi, Claudio
    Lettieri, Corrado
    Visconti, Luigi Oltrona
    CORONARY ARTERY DISEASE, 2018, 29 (04) : 309 - 315
  • [37] Effect of Serum IL-6 Levels on the Progression of Non-Target Lesions in Patients after Coronary Stenting
    Sha, Xiang
    Wang, Wei
    Qiu, Jie
    Wang, Ruzhu
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (07)
  • [38] Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: The prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation)
    Poyet, Raphael
    Cuisset, Thomas
    Frere, Corinne
    Quilici, Jacques
    Gaborit, Benedicte
    Moro, Pierre-Julien
    Camoin, Laurence
    Morange, Pierre-Emmanuel
    Alessi, Marie-Christine
    Bonnet, Jean-Louis
    THROMBOSIS RESEARCH, 2010, 126 (05) : E397 - E399
  • [39] Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting
    Eisen, Alon
    Bhatt, Deepak L.
    HEART, 2017, 103 (11) : 871 - 884
  • [40] Effect of Atorvastatin and Clopidogrel Co-Administration After Coronary Stenting in Korean Patients With Stable Angina
    Kim, Goeng Bae
    Kim, Jeong Kyung
    Park, Sul
    Jeong, Jae Jin
    Yoon, Hyung Sik
    Ko, Sang Hun
    Ko, Jae Ee
    Park, Soo Jin
    Nam, Seon Woo
    Lee, Jae Hwan
    Hyon, Min Soo
    KOREAN CIRCULATION JOURNAL, 2011, 41 (01) : 28 - 33